Treatment of Fulminant Hepatic Failure

Publisher Website
Google Scholar
Abstract
IN this issue of the Journal Davis and his colleagues present a series of case reports of fulminant hepatitis to make the point that a significant number of patients with this distressing clinical picture (37.5 per cent) can survive without therapeutic procedures any more drastic than high doses of steroids. This is quite different from information contained in the second progress report of the Fulminant Hepatic Failure Surveillance Study now under way.1 In this collected series, the results of which are sent by mail to those who agree to submit data on all patients they see, there have now been . . .

This publication has 1 reference indexed in Scilit: